Chimerix Inc (CMRX)

May 10, 2025

StockNews.com Initiates Coverage on Chimerix (NASDAQ:CMRX) - Defense World

May 10, 2025

May 02, 2025

Halper Sadeh LLP, bluebird bio, Inc., Walgreens Boots Alliance, Chimerix, Inc. - Olean Times Herald

May 02, 2025

May 02, 2025

Chimerix (NASDAQ:CMRX) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 02, 2025

Apr 30, 2025

Chimerix, Inc. to Host Earnings Call - ACCESS Newswire

Apr 30, 2025

Apr 30, 2025

Why Chimerix Inc. (CMRX) is Surging in 2025 - Insider Monkey

Apr 30, 2025

Apr 29, 2025

Investor Network: Chimerix, Inc. to Host Earnings Call - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

Geode Capital Management LLC Lowers Stock Holdings in Chimerix, Inc. (NASDAQ:CMRX) - Defense World

Apr 29, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 22, 2025

Jazz Pharmaceuticals Acquires Chimerix for $935M - Contract Pharma

Apr 22, 2025

Apr 21, 2025

Jazz Pharmaceuticals Completes $935 Million Acquisition of Chimerix - marketscreener.com

Apr 21, 2025

Apr 21, 2025

Jazz Pharmaceuticals acquires Chimerix for $935 million By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

Chimerix Terminates Loan and Delists from Nasdaq - TipRanks

Apr 21, 2025

Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ St - GuruFocus

Apr 21, 2025

Apr 21, 2025

Jazz Pharmaceuticals (JAZZ) Completes Acquisition of Chimerix - StreetInsider

Apr 21, 2025

Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix - TipRanks

Apr 21, 2025

Apr 21, 2025

Jazz Pharmaceuticals acquires Chimerix for $935 million - Investing.com

Apr 21, 2025

Apr 21, 2025

Jazz Pharmaceuticals Completes Acquisition of Chimerix | JAZZ Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Jazz's $935M Chimerix Buyout Targets First-Ever Treatment for Rare Brain Cancer, FDA Verdict Looms - Stock Titan

Apr 21, 2025

Apr 16, 2025

Chimerix (NASDAQ:CMRX) Now Covered by StockNews.com - Defense World

Apr 16, 2025

Apr 10, 2025

Chimerix stock soars to 52-week high, hits $8.54 By Investing.com - Investing.com South Africa

Apr 10, 2025

Apr 10, 2025

Chimerix stock soars to 52-week high, hits $8.54 - Investing.com

Apr 10, 2025

Apr 07, 2025

Unlocking Investment Potential Discover the Power of Magical Signals Bullish Signal - AInvest

Apr 07, 2025

Apr 07, 2025

Top 3 Health Care Stocks That May Crash In Q2 - Benzinga

Apr 07, 2025

Apr 02, 2025

Chimerix stock soars to 52-week high, hits $8.53 By Investing.com - Investing.com Australia

Apr 02, 2025

Apr 02, 2025

Chimerix stock soars to 52-week high, hits $8.53 - Investing.com

Apr 02, 2025

Apr 02, 2025

Is Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025? - MSN

Apr 02, 2025

Apr 01, 2025

Jazz Pharmaceuticals, Chimerix HSR waiting period expired on March 31 - MLex

Apr 01, 2025

Mar 31, 2025

11 Best Performing NASDAQ Stocks So Far in 2025 - Insider Monkey

Mar 31, 2025

Mar 31, 2025

Exploring US High Growth Tech Stocks In March 2025 - simplywall.st

Mar 31, 2025

Mar 26, 2025

Chimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025 - Yahoo

Mar 26, 2025

Mar 24, 2025

11 Best Performing Stocks So Far In 2025 - Insider Monkey

Mar 24, 2025

Mar 24, 2025

Jazz strikes the chord with $935m Chimerix acquisition - BioXconomy

Mar 24, 2025

Mar 24, 2025

Chimerix Reports 2024 Losses Amid Acquisition News - TipRanks

Mar 24, 2025

Mar 21, 2025

Chimerix earnings missed, revenue fell short of estimates By Investing.com - Investing.com Canada

Mar 21, 2025

Mar 21, 2025

Chimerix Inc Reports Q4 2024 EPS of -$0.25, Beating Estimates; R - GuruFocus.com

Mar 21, 2025

Mar 21, 2025

The buildup to Chimerix's $935M exit to Jazz, with more than half a dozen parties intrigued - Endpoints News

Mar 21, 2025

Mar 21, 2025

Chimerix: Q4 Earnings Snapshot - mySA

Mar 21, 2025

Mar 21, 2025

Chimerix Inc. (CMRX) reports earnings - Quartz

Mar 21, 2025

Mar 21, 2025

CHIMERIX INC SEC 10-K Report - TradingView

Mar 21, 2025

Mar 21, 2025

Chimerix Reports Fourth Quarter and Year End 2024 Financial Results - The Manila Times

Mar 21, 2025